BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions
FRANKLIN LAKES, N.J. and OREM, Utah, Jan. 30, 2024 -- (Healthcare Sales & Marketing Network) -- BD (Becton... Diagnostics, Oncology BD , Techcyte, cervical cancer, Pap smear
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cervical Cancer | Cytology | Information Technology | Marketing | Papanicolaou (Pap) Smear | Pathology | Pharmaceuticals